Collecting Duct Carcinoma: Characteristics and Survival Outcomes From UroCCR Database (CDCSurv UroCCR n°141)

This publication has 20 references indexed in Scilit:

• Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
  Annals of Oncology, 2024
• French AFU Cancer Committee Guidelines - Update 2022-2024: management of kidney cancer
  Progrès en Urologie, 2022
• The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
  European Urology, 2022
• Cabozantinib as First-line Treatment in Patients With Metastatic Collecting Duct Renal Cell Carcinoma
  JAMA Oncology, 2022
• Approach for reclassification of collecting duct carcinoma and comparative histopathological analysis with SMARCB1/INI1-deficient renal cell carcinoma and fumarate hydratase-deficient renal cell carcinoma
  Human Pathology, 2022
• Collecting Duct Carcinoma of the Kidney: Analysis of 74 Cases From Multiple Centers
  Urology, 2022
• Sorafenib in combination with gemcitabine plus cisplatin chemotherapy in metastatic renal collecting duct carcinoma: A prospective, multicentre, single-arm, phase 2 study
  European Journal of Cancer, 2018
• Characteristics and Outcomes of Tumors Arising From the Distal Nephron
  Urology, 2012
• Prospective Multicenter Phase II Study of Gemcitabine Plus Platinum Salt for Metastatic Collecting Duct Carcinoma: Results of a GETUG (Groupe d’Etudes des Tumeurs Uro-Génitales) Study
  Journal of Urology, 2007
• Collecting duct carcinoma of the kidney: CT and pathologic correlation
  European Journal of Radiology, 2006